Telemedicine Education for Rural Children With Asthma

This study has been completed.
Sponsor:
Collaborator:
University of Arkansas
Information provided by (Responsible Party):
Arkansas Children's Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT00964301
First received: August 20, 2009
Last updated: August 12, 2014
Last verified: August 2014

August 20, 2009
August 12, 2014
August 2009
July 2012   (final data collection date for primary outcome measure)
The investigators will examine changes in asthma symptoms control and health outcomes in the intervention group compared to a usual care group. [ Time Frame: One year ] [ Designated as safety issue: No ]
We will examine changes in asthma symptoms control and health outcomes in the intervention group compared to a usual care group. We will compare the change between the baseline and the study completion. [ Time Frame: One year ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00964301 on ClinicalTrials.gov Archive Site
The investigators will examine changes in asthma knowledge, self-efficacy, and quality of life of the intervention participants and their caregivers compared to a usual care group. [ Time Frame: One year ] [ Designated as safety issue: No ]
We will examine changes in asthma knowledge, self-efficacy, and quality of life of the intervention participants and their caregivers compared to a usual care group. We will compare changes, between baseline and at study completion. [ Time Frame: One year ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Telemedicine Education for Rural Children With Asthma
Telemedicine Education for Rural Children With Asthma

The investigators will implement an interactive school-based telemedicine education program for rural low-income, minority children with asthma, their caregivers, and school nurses in the Delta region of Arkansas.

Specific aims:

  1. The investigators will examine changes in asthma symptoms control and other health outcomes such as activity levels and family/child emotional health in the intervention group compared to a usual care group.
  2. The investigators will examine changes in asthma knowledge, self-efficacy, and quality of life in the intervention participants and their caregivers compared to a usual care group.

The investigators will conduct a prospective study to examine the impact of an interactive, telemedicine asthma intervention among children living in the rural Delta region of Arkansas.

Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Asthma
  • Other: Telemedicine Education

    Student Asthma Education. Each student will engage in 6 age-appropriate sessions on various aspects of asthma health.

    Caregiver Asthma Education. The primary caregiver will engage in 2 asthma education sessions.

    School Nurse Asthma Education. School nurses will participate in 2 sessions.

    Primary Care Provider (PCP) Communication. The PCP of the intervention group participant will be notified of his/her patient's baseline asthma assessment. They will receive updates summarizing each telemedicine intervention.

  • Other: Usual care
    Participants will receive asthma care by their PCP with no education sessions or PCP communications by the research staff.
  • Experimental: Intervention Group
    Participants, caregivers and school nurse will attend telemedicine education sessions at school.
    Intervention: Other: Telemedicine Education
  • Active Comparator: Usual care
    Usual care participant will receive routine care from their primary care provider.
    Intervention: Other: Usual care

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
106
January 2014
July 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Study participants will be English-speaking children ages 7-17 years with physician-diagnosed asthma and/or active symptoms in the previous 12 months.
  • Active symptoms include one or more of the following:

    • experience daytime wheezing, shortness of breath, and/or coughing two or more times a week for the last 4 weeks;
    • nighttime wheezing, shortness of breath and/or cough more than once a week;
    • take asthma medication more than two days a week;
    • have been treated in a hospital or emergency department two or more times in the last two years for asthma symptoms;
    • have been treated in a hospital or emergency department two or more times in the last two years for asthma symptoms have episodes of asthma-like symptoms when playing/exercising.
  • Potentially eligible participants will be screened using an asthma screener to confirm eligibility.

Exclusion Criteria:

  • Children with significant underlying respiratory disease other than asthma (such as cystic fibrosis) or significant co-morbid conditions (such as severe developmental delay or cerebral palsy) will be excluded from the study.
  • The primary caregiver and child will be asked questions via telephone interview about how asthma affects the child every day. Children with no telephone number or contact telephone number will be excluded.
Both
7 Years to 17 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00964301
110807
Yes
Arkansas Children's Hospital Research Institute
Arkansas Children's Hospital Research Institute
University of Arkansas
Principal Investigator: Tamara T. Perry, M.D., FAAP University of Arkansas
Arkansas Children's Hospital Research Institute
August 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP